| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8945198 | Gynecologic Oncology | 2018 | 7 Pages |
Abstract
TTFields combined with weekly paclitaxel were safe in platinum-resistant recurrent ovarian cancer and warrants evaluation in a randomized phase 3 trial.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Ignace Vergote, Roger von Moos, Luis Manso, Els Van Nieuwenhuysen, Nicole Concin, Cristiana Sessa,